Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse modelsCRANSTON, Aaron N; PONDER, Bruce A. J.Cancer research (Baltimore). 2003, Vol 63, Num 16, pp 4777-4780, issn 0008-5472, 4 p.Article

C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RETREYNOLDS, Lucinda; JONES, Ken; WINTON, Douglas J et al.Oncogene (Basingstoke). 2001, Vol 20, Num 30, pp 3986-3994, issn 0950-9232Article

Poly(ADP-Ribose) Polymerase-1 Inhibitor Treatment Regresses Autochthonous Brca2/p53-Mutant Mammary Tumors In vivo and Delays Tumor Relapse in Combination with CarboplatinHAY, Trevor; MATTHEW, James R; CLARKE, Alan R et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 9, pp 3850-3855, issn 0008-5472, 6 p.Article

Tumor Growth Inhibition by Olaparib in BRCA2 Germline-Mutated Patient-Derived Ovarian Cancer Tissue XenograftsKORTMANN, Ursula; MCALPINE, Jessica N; HUNTSMAN, David G et al.Clinical cancer research (Print). 2011, Vol 17, Num 4, pp 783-791, issn 1078-0432, 9 p.Article

The ret^C620R mutation affects renal and enteric development in a mouse model of Hirschsprung's diseaseCARNITI, Cristiana; BELLUCO, Sara; RICCARDI, Elena et al.The American journal of pathology. 2006, Vol 168, Num 4, pp 1262-1275, issn 0002-9440, 14 p.Article

RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2BCRANSTON, Aaron N; CARNITI, Cristiana; PIERONI, Marco A et al.Cancer research (Baltimore). 2006, Vol 66, Num 20, pp 10179-10187, issn 0008-5472, 9 p.Article